510(k) device
Delta III Pro
Dornier Medtech America, Inc. · Lithotriptor, Extracorporeal Shock-Wave, Urological (LNS, Class II) · First FDA decision Feb 22, 2023, newest Feb 22, 2023Kidney stones
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "Delta III Pro"
MAUDE reports
1
Brand "Delta III Pro", since 2015
PubMed studies
2
Mentioning "Delta III Pro"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Delta III Pro
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Delta III Pro510(k)
K221903 · Decided Feb 22, 2023 · 237 days after receipt
Device type: Lithotriptor, Extracorporeal Shock-Wave, Urological (LNS) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Delta III Pro", any status and sponsor, newest update first.
No registered device study names "Delta III Pro".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Delta III Pro", and for the whole product code for context.
This brand
1 reports: 0 malfunction, 1 injury, 0 death
Whole product code LNS
605 reports: 95 malfunction, 498 injury, 11 death
Newest reports for this brand
- DORNIER DELTA III PROInjury
9611388-2023-00018 · Received Aug 8, 2023
Device type: Lithotriptor, Extracorporeal Shock-Wave, Urological (LNS)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Hematoma
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Delta III Pro"[tiab]. The summary above synthesizes these.
- Predictors of treatment failure and outcome assessment of extracorporeal shock wave lithotripsy with the Dornier Compact Delta® III Pro: experience from the first 1000 treatments.
Salah M, Al-Ghashmi M, Tallai B, et al. · Arch Ital Urol Androl · 2025
- Performance of 'Triple-D' and 'Quadruple-D' scores compared to a regression-based predictive model for treatment outcomes in extracorporeal shock wave lithotripsy.
Salah M, Al-Ghashmi M, Tallai B, et al. · Arch Ital Urol Androl · 2025Comparative Study
Other devices of this type
Also filed under product code LNS.
- Delta III LithotripterDornier Medtech America, Inc. · 510(k) 2020
- Break WaveSonomotion, Inc. · 510(k) 2026
- Tripter X-1 CompactDirex Systems Corp. · 510(k) 2004
- Extracorporeal Shock Wave Lithotripter (U200)Shenzhen Wikkon Precision Technologies Co., Ltd. · 510(k) 2025
- LM-9300 Plus LithotripterLite-Med, Inc. · 510(k) 2023
- Modulith SLX-F2Karl Storz Endoscopy America · 510(k) 2021
- Gemini XXP-HPDornier Medtech America · 510(k) 2015
- LM-9300 ELMA LithotripterLite-Med, Inc. · 510(k) 2015
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.